Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate Anhydrous vs Nasonex in Seasonal Allergic Rhinitis
NCT01523236Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2011; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01523236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523236.